Article

The combination of transcriptome and Mendelian randomization reveals clinical and immuno-functional biomarkers of alternative splicing regulation associated with planar cell polarity signaling pathways in pan-cancer

2024-03-28

Abstract excerpt

<h4>Background: </h4> The intricate interplay between alternative splicing (AS) events and the planar cell polarity (PCP) signaling pathway is known to play a crucial role in cancer initiation and progression. Understanding the prognostic implications and immunological features of PCP-related AS events can unveil novel biological markers and potential targets for immunotherapy. Methods We sourced genes associated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7532ea96-e59d-5bc3-b086-d1230b71941a
DOI: 10.21203/rs.3.rs-4115366/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The combination of transcriptome and Mendelian randomization reveals clinical and immuno-functional biomarkers of alternative splicing regulation associated with planar cell polarity signaling pathways in pan-cancerDOI 10.21203/rs.3.rs-4115366/v1Read

Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinomaSemantic proximity Read

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.Semantic proximity Read

Conditional activation of immune-related signatures and prognostic significance: a pan-cancer analysisSemantic proximity Read

Pan-cancer landscape of basement membrane: multi-omics research and single-cell sequencing validation.Semantic proximity Read

Immune Cell Profiles and Novel Insights Into Cancer Risk: A Focus on Oral and Pharyngeal Cancer.Semantic proximity Read

Prognostic significance and immunologic features of the paired-box (PAXs) family: a pan-cancer multi- omics analysisSemantic proximity Read

Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer.Semantic proximity Read

A comprehensive pan-cancer analysis identifies AP1S1 as a novel biomarker for predicting prognosis and immunotherapy responseSemantic proximity Read

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-CancerSemantic proximity Read

Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancerSemantic proximity Read

AI-Based Modeling Reveals APOD⁺ Cancer-Associated Fibroblasts as Key Regulators of Pan-Cancer Therapeutic ResponseSemantic proximity Read

Identification of a Potential Alternative Splicing Prognostic Signature Associated With Immune Infiltrates of Ovarian CancerSemantic proximity Read